Martin E W Hemels

3.8k total citations · 1 hit paper
63 papers, 484 citations indexed

About

Martin E W Hemels is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Martin E W Hemels has authored 63 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 13 papers in Internal Medicine and 9 papers in Economics and Econometrics. Recurrent topics in Martin E W Hemels's work include Atrial Fibrillation Management and Outcomes (43 papers), Cardiac Arrhythmias and Treatments (22 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Martin E W Hemels is often cited by papers focused on Atrial Fibrillation Management and Outcomes (43 papers), Cardiac Arrhythmias and Treatments (22 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Martin E W Hemels collaborates with scholars based in Netherlands, United States and United Kingdom. Martin E W Hemels's co-authors include Menno V. Huisman, Henri H. Versteeg, Frederikus A. Klok, Serge A. Trines, Arie J. Verschoor, Cihan Ay, Arif Elvan, Ron Pisters, Michiel Rienstra and Frans H. Rutten and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Martin E W Hemels

50 papers receiving 478 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

2023 77 citations Sander van Doorn, Melchior C. Nierman et al. profile →

Peers

Countries citing papers authored by Martin E W Hemels

Since Specialization

Citations

This map shows the geographic impact of Martin E W Hemels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E W Hemels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E W Hemels more than expected).

Fields of papers citing papers by Martin E W Hemels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin E W Hemels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E W Hemels. The network helps show where Martin E W Hemels may publish in the future.

Co-authorship network of co-authors of Martin E W Hemels

This figure shows the co-authorship network connecting the top 25 collaborators of Martin E W Hemels. A scholar is included among the top collaborators of Martin E W Hemels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin E W Hemels. Martin E W Hemels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study 2025 ·Journal of the American Heart Association ·(unknown), (unknown), (unknown), (unknown), Robert G. Tieleman, (unknown), Martin E W Hemels, Mirko De Melis, Ulrich Schotten, Dominik Linz, Harry J.G.M. Crijns, Isabelle C. Van Gelder, Michiel Rienstra, (unknown)	2
2	Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration 2024 ·Heart ·(unknown), (unknown), Dominik Linz, Harry J.G.M. Crijns, Robert G Tieleman, Martin E W Hemels, Mirko De Melis, Ulrich Schotten, Mads Brix Kronborg, Jens Cosedis Nielsen, Isabelle C. Van Gelder, Michiel Rienstra	3
3	The Use of Oral Anticoagulation Is Not Independently Associated with Mortality in Frail Older Patients with Repeated Falls 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Martin E W Hemels, Tjeerd Germans, Joris R. de Groot, René W. M. M. Jansen	2
4	Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands 2023 ·BMJ Open ·(unknown), R.W.M.M. Jansen, Joris R. de Groot, (unknown), Martin E W Hemels, Renée A. Douma, (unknown), Kees Brinkman, Hazra S. Moeniralam, Martijn D. de Kruif, Tom Dormans, Brent Appelman, Auke C. Reidinga, (unknown), (unknown), (unknown), Martijn Beudel, Suat Şimşek	3
5	Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial 2023 ·PLoS ONE ·(unknown), Geert‐Jan Geersing, (unknown), Martin E W Hemels, Michiel Rienstra, Isabelle C. Van Gelder, Maarten van Smeden, David van Klaveren, David M. Kent, Frans H. Rutten, Sander van Doorn	9
6	Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation 2023 ·Heart ·(unknown), (unknown), Alexander H. Maass, (unknown), Martin E W Hemels, Robert G Tieleman, (unknown), Mirko De Melis, Dominik Linz, Ulrich Schotten, (unknown), Harry J.G.M. Crijns, Isabelle C. Van Gelder, Jens Cosedis Nielsen, Michiel Rienstra	2
7	Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study 2023 ·EP Europace ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Harry J.G.M. Crijns, Martin E W Hemels, Robert G Tieleman, Mirko De Melis, Ulrich Schotten, Dominik Linz, Isabelle C. Van Gelder, Michiel Rienstra, (unknown)	13
8	Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study 2023 ·Open Heart ·Bart A. Mulder, (unknown), (unknown), (unknown), (unknown), Harry J.G.M. Crijns, Bastiaan Geelhoed, Yuri Blaauw, Martin E W Hemels, Robert G Tieleman, (unknown), Mirko De Melis, Ulrich Schotten, Dominik Linz, Isabelle C. Van Gelder, Michiel Rienstra	1
9	Screening over 100 000 patients in 39 general practices in the Netherlands for anticoagulation underprescription in atrial fibrillation: a descriptive, cross-sectional study 2023 ·BMJ Open ·(unknown), Ron Pisters, (unknown), (unknown), Sander van Doorn, (unknown), (unknown), Freek W.A. Verheugt, Martin E W Hemels	2
10	Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), Suzanne C. Cannegieter, Hans Gelderblom, Marcel M.C. Hovens, Menno V. Huisman, Tom van der Hulle, Serge A. Trines, (unknown), Henri H. Versteeg, Martin E W Hemels, Frederikus A. Klok	6
11	Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study 2021 ·Acta cardiologica. Supplementum ·(unknown), Martin E W Hemels, Frank Cools, Harry J.G.M. Crijns, Laetitia Yperzeele, Peter Vanacker, Ivan Blankoff, Patrizio Lancellotti, Georges H. Mairesse, (unknown), Rubén Casado-Arroyo, (unknown), Michel De Pauw, Thomas Vanassche, Carlo de Asmundis, Paulus Kirchhof, Raffaele De Caterina, Joris R. de Groot, (unknown)	0
12	Factors facilitating and hindering the implementation of the European Society of Cardiology Syncope Guidelines at the Emergency Department: A nationwide qualitative study 2021 ·International Journal of Cardiology ·(unknown), Leti van Bodegom‐Vos, Michele Brignole, (unknown), Bas de Groot, Evert C. A. Kaal, Martin E W Hemels, Frederik J. de Lange, J. Gert van Dijk, Roland D. Thijs	4
13	Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients 2020 ·Surgery for Obesity and Related Diseases ·Sophie L. van Veldhuisen, Gijs van Woerden, Martin E W Hemels, (unknown), Rudolf A. de Boer, Michiel Rienstra, Dirk J. van Veldhuisen, Eric J. Hazebroek	0
14	Quality of life after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation: results from the SCALAF trial 2019 ·Clinical Research in Cardiology ·(unknown), Ahmet Adiyaman, Rypko Beukema, Jaap Jan J. Smit, Peter Paul H.M. Delnoy, Martin E W Hemels, Hauw T. Sie, Anand R. Ramdat Misier, Arif Elvan	7
15	Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial 2019 ·BMJ Open ·(unknown), Sander van Doorn, Arno W. Hoes, Melchior C. Nierman, (unknown), Huiberdina L. Koek, Martin E W Hemels, Menno V. Huisman, Kit C. B. Roes, (unknown), (unknown), Frans H. Rutten, Geert‐Jan Geersing	11
16	<p>When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics</p> 2019 ·Vascular Health and Risk Management ·(unknown), Ron Pisters, Martin E W Hemels, Menno V. Huisman, Hugo Ten Cate, Marco Alings	13
17	Second-generation cryoballoon ablation for recurrent atrial fibrillation after an index cryoballoon procedure: a staged strategy with variable balloon size 2018 ·Journal of Interventional Cardiac Electrophysiology ·Sjoerd Westra, (unknown), (unknown), Reinder Evertz, Martin E W Hemels, Rypko Beukema, Carlo de Asmundis, Marc A. Brouwer, Gian‐Battista Chierchia	11
18	Hervatten van antistolling na een hersenbloeding 2015 ·Data Archiving and Networked Services (DANS) ·L. Jaap Kappelle, (unknown), Steven A. J. Chamuleau, Koen M. van Nieuwenhuizen, Martin E W Hemels, Catharina J.M. Klijn	1
19	Hervatten van antistolling na een hersenbloeding - Resumption of antithrombotic treatment after an intracerebral haemorrhage 2015 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·L. Jaap Kappelle, Frederick J. A. Meijer, Steven A. J. Chamuleau, Koen M. van Nieuwenhuizen, Martin E W Hemels, Catharina J.M. Klijn	1
20	Patients’ Priorities For Treatment In Severe Asthma 2015 ·Value in Health ·D Whalley, Brett Hauber, (unknown), Joshua Posner, Lynda Doward, Bennett Levitan, Martin E W Hemels, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact